• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about Biogen Inc

    Recent news which mentions Biogen Inc

    < Previous 1 2 3 4 Next >
    Stocks making the biggest moves midday: Spotify, RTX, General Electric and more
    Tags General Motors Co Markets Economy
    From CNBC.com News
    Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
    Tags Business News Biotechnology Health care industry
    From CNBC.com News
    5 things to know before the stock market opens Tuesday
    Tags Citigroup Inc Morgan Stanley Economy
    From CNBC.com News
    Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
    Tags Breaking news Companies Alzheimer's disease
    From CNBC.com News
    Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
    Tags Biotech and Pharmaceuticals Science Health & Science
    From CNBC.com News
    Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
    Tags Eisai Co Ltd Business News Pharmaceuticals
    From CNBC.com News
    Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more
    Tags TG Therapeutics Inc Business Finance
    From CNBC.com News
    Stocks making the biggest premarket moves: Levi Strauss, Biogen, Alibaba and more
    Tags Economy Bloom Energy Corp Market Insider
    From CNBC.com News
    Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug
    Tags Asia Markets Science Pharmaceuticals
    From CNBC.com News
    FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
    Tags Eisai Co Ltd Breaking News: Business Politics
    From CNBC.com News
    Stocks making the biggest moves midday: JD.Com, Biogen, Oracle and more
    Tags Zions Bancorporation NA Markets Biogen Inc
    From CNBC.com News
    FDA advisors to weigh whether Alzheimer's drug Leqembi should receive full approval
    Tags US Top News and Analysis Business US: News
    From CNBC.com News
    Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
    Tags Health care industry Biotechnology Biogen Inc
    From CNBC.com News
    Jim Cramer expects defensive stocks to be resilient as debt ceiling talks drag on
    Tags Eli Lilly and Co Stock Picks Business
    From CNBC.com News
    Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
    Tags Health & Science Biotech and Pharmaceuticals Eli Lilly and Co
    From CNBC.com News
    Stocks making the biggest moves premarket: Starbucks, AMD, Pearson, PacWest & more
    Tags Eli Lilly and Co Western Alliance Bancorp Business
    From CNBC.com News
    Bipartisan attorneys general call on Medicare to cover Alzheimer's treatments
    Tags Biotech and Pharmaceuticals Coronavirus Health & Science
    From CNBC.com News
    Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease
    Tags Epidemics Eisai Co Ltd Politics
    From CNBC.com News
    Alzheimer's: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says
    Tags Policy U/S/ Economy US: News
    From CNBC.com News
    Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
    Tags Biotech and Pharmaceuticals Health & Science Science
    From CNBC.com News
    FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease
    Tags Drug approvals Breaking news Companies
    From CNBC.com News
    Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says
    Tags Health care industry Biotechnology Pharmaceuticals
    From CNBC.com News
    Eli Lilly says experimental Alzheimer's drug reduces brain plaque in early study
    Tags US: News Companies Breaking news
    From CNBC.com News
    FDA advisors reject Biogen's ALS drug for rare and aggressive form of the disease
    Tags Pharmaceuticals Biogen Inc Health & Science
    From CNBC.com News
    FDA staff says Biogen's ALS drug may have a 'clinical benefit' on a rare form of the disease
    Tags Breaking News: Business Business News Pharmaceuticals
    From CNBC.com News
    Veterans' Health will cover Alzheimer's treatment Leqembi for some patients
    Tags World News Biotechnology Health care industry
    From CNBC.com News
    FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July
    Tags Biotech and Pharmaceuticals Coronavirus Health & Science
    From CNBC.com News
    Medicare rejects Alzheimer's Association request for unrestricted coverage of treatments like Leqembi
    Tags Health & Science Coronavirus Biotech and Pharmaceuticals
    From CNBC.com News
    Stocks making the biggest moves midday: Deere, Airbnb, AutoNation, Moderna and more
    Tags Roku Inc stocks Biogen Inc
    From CNBC.com News
    Senators call on Medicare to offer broad coverage of Alzheimer's treatments as public pressure grows
    Tags Pandemics Eisai Co Ltd Epidemics
    From CNBC.com News
    < Previous 1 2 3 4 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.